Lv41
470 积分 2025-02-19 加入
Small Cell Lung Cancer: A Review
7小时前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
7小时前
已完结
Advancing therapeutics in small-cell lung cancer
7小时前
已完结
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases
14天前
已完结
A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer
2个月前
已完结
Risk-based local radiotherapy in oligometastatic NSCLC in the era of immunotherapy: a multi-centric cohort study
2个月前
已关闭
Optimal Duration of Consolidation Durvalumab Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer: A Multi-institutional Retrospective Study
2个月前
已完结
[18F]FDG PET/CT for predicting neoadjuvant PD-L1 blockade monotherapy treatment response in patients with locally advanced esophageal squamous cell carcinoma: a preliminary study
3个月前
已完结
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial
3个月前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
3个月前
已完结
皖公网安备34019202002308
